DMARD/corticosteroids prevented progression of ACPA-positive RA Healio Researchers in London analyzed data from the CARDERA control trial of 431 patients with early, active rheumatoid arthritis (RA; <2 years duration) who were randomly assigned methotrexate, methotrexate and ciclosporin, methotrexate and prednisolone or ... |
